Associated Papers
Genotypic analysis of a large cohort of patients with suspected atypical hemolytic uremic syndrome.
Connaughton DM et al.
Journal of Molecular Medicine (berlin, Germany), 2023
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Davis AA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2023
36693175 (PubMed )
Supplement: ccr-22-2177_supplementary_data_s1_suppds1.xlsx › Variants
High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome.
Kandari S et al.
Nephrology (carlton, Vic.), 2022
Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy.
Haydock L et al.
Journal of Molecular Medicine (berlin, Germany), 2022
34714369 (PubMed )
Supplement: 109_2021_2102_MOESM1_ESM.docx
Case 19-2018: A 15-Year-Old Girl with Acute Kidney Injury.
Kao AY et al.
The New England Journal of Medicine, 2018
Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C et al.
Blood, 2009
Select a paper to view details